CompanyAmgen Europe B.V.
ATC codeL01XX51
EU authorised2015-12-16
· 10 yr ago
Flags
—
EMA EPAR
Evidence dossier ↗
Imlygic CONFIRMED
talimogene laherparepvec · Melanoma
Current stage: 6 · first detected 2026-06-25
Also known as: imlygic
Nordic decisions
| Country | Body | Verdict | Date | Source |
|---|---|---|---|---|
| Norge | Beslutningsforum | Innføres ikke | 2018-06-11 | link |
Status timeline
| Date | Body | Status | Stage | Source |
|---|---|---|---|---|
| 2026-06-25 | EMA | authorised | 4 | link |
| 2026-06-30 | EMA | authorised | 4 | link |
| 2026-07-07 | EMA | authorised | 4 | link |
| 2026-07-14 | EMA | authorised | 4 | link |
| 2026-07-21 | EMA | authorised | 4 | link |
| 2026-07-28 | EMA | authorised | 4 | link |
| 2026-08-04 | EMA | authorised | 4 | link |
| 2026-08-05 | EMA | authorised | 4 | link |
| 2026-08-05 | EMA | authorised | 4 | link |
| 2026-08-11 | EMA | authorised | 4 | link |
| 2026-08-18 | EMA | authorised | 4 | link |